YAP promotes erlotinib resistance in human non-small cell lung cancer cells

Ping‐Chih Hsu(Chang Gung University), Liang You(UCSF Helen Diller Family Comprehensive Cancer Center)

Oncotarget

July 7, 2016

10.18632/oncotarget.10458

Cited by 116

Related Papers

YAP regulates PD-L1 expression in human NSCLC cells

|Oncotarget|2017|128

Identification of hematein as a novel inhibitor of protein kinase CK2 from a natural product library

|BMC Cancer|2009|30

Forced Overexpression of Signal Transducer and Activator of Transcription 3 (STAT3) Activates Yes-Associated Protein (YAP) Expression and Increases the Invasion and Proliferation Abilities of Small Cell Lung Cancer (SCLC) Cells

|Biomedicines|2022|13

Flavones and Aminoflavones Increase the Cytotoxicity of <scp>NK</scp> Cells in Human Non‐Small Cell Lung Cancer

|Journal of Cellular and Molecular Medicine|2026|1